Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMRN | Amarin Corporation Plc Sponsored ADR | -3.24% | 18.40 | 1.8% | $102.70m | |
| UTHR | United Therapeutics Corporation | -1.84% | 76.08 | 14.3% | $73.38m | |
| JAZZ | Jazz Pharmaceuticals Plc | -1.99% | 131.70 | 2.3% | $67.63m | |
| SAGE | SAGE Therapeutics, Inc. | -2.96% | 177.25 | 8.7% | $65.79m | |
| MDCO | Medicines Company | -2.58% | 35.46 | 21.8% | $56.26m | |
| ARQL | ArQule, Inc. | -4.00% | 10.07 | 0.7% | $53.88m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | -1.54% | 170.96 | 6.2% | $51.44m | |
| PRGO | Perrigo Co. Plc | -0.96% | 44.08 | 6.8% | $51.33m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -1.83% | 79.90 | 18.6% | $49.26m | |
| CTLT | Catalent Inc | -0.98% | 52.72 | 2.4% | $43.55m | |
| HZNP | Horizon Pharma plc | -1.26% | 23.47 | 6.7% | $38.54m | |
| ICLR | ICON Plc | 0.62% | 148.55 | 4.1% | $36.70m | |
| ZYNE | Zynerba Pharmaceuticals Inc | -2.55% | 13.00 | 8.3% | $28.30m | |
| AXSM | Axsome Therapeutics, Inc. | -3.62% | 23.30 | 2.1% | $27.69m | |
| PTLA | Portola Pharmaceuticals, Inc. | -4.20% | 26.26 | 7.5% | $27.00m |
Company Profile
Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel antibiotics for serious and life-threatening bacterial infections. It is currently developing a product candidate, eravacycline, a fully synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Watertown, MA.